IKZF1 Antibody - #DF6659

Product: | IKZF1 Antibody |
Catalog: | DF6659 |
Description: | Rabbit polyclonal antibody to IKZF1 |
Application: | WB IHC |
Reactivity: | Human, Mouse, Rat |
Prediction: | Pig, Horse, Rabbit, Dog |
Mol.Wt.: | 50-70kD; 58kD(Calculated). |
Uniprot: | Q13422 |
RRID: | AB_2838621 |
Related Downloads
Protocols
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# DF6659, RRID:AB_2838621.
Fold/Unfold
CLL associated antigen KW 6; DNA-binding protein Ikaros; hIk 1; Hs.54452; IK1; Ikaros (zinc finger protein); IKAROS; IKAROS family zinc finger 1 (Ikaros); Ikaros family zinc finger protein 1; Ikzf1; IKZF1_HUMAN; LYF1; Lymphoid transcription factor LyF-1; PRO0758; Zinc finger protein subfamily 1A 1 (Ikaros); Zinc finger protein subfamily 1A 1; Zinc finger protein, subfamily 1A, member 1; ZNFN1A1;
Immunogens
Abundantly expressed in thymus, spleen and peripheral blood Leukocytes and lymph nodes. Lower expression in bone marrow and small intestine.
- Q13422 IKZF1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MDADEGQDMSQVSGKESPPVSDTPDEGDEPMPIPEDLSTTSGGQQSSKSDRVVASNVKVETQSDEENGRACEMNGEECAEDLRMLDASGEKMNGSHRDQGSSALSGVGGIRLPNGKLKCDICGIICIGPNVLMVHKRSHTGERPFQCNQCGASFTQKGNLLRHIKLHSGEKPFKCHLCNYACRRRDALTGHLRTHSVGKPHKCGYCGRSYKQRSSLEEHKERCHNYLESMGLPGTLYPVIKEETNHSEMAEDLCKIGSERSLVLDRLASNVAKRKSSMPQKFLGDKGLSDTPYDSSASYEKENEMMKSHVMDQAINNAINYLGAESLRPLVQTPPGGSEVVPVISPMYQLHKPLAEGTPRSNHSAQDSAVENLLLLSKAKLVPSEREASPSNSCQDSTDTESNNEEQRSGLIYLTNHIAPHARNGLSLKEEHRAYDLLRAASENSQDALRVVSTSGEQMKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHRFHMS
Predictions
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q13422 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
S13 | Phosphorylation | P67870 (CSNK2B) , P68400 (CSNK2A1) | Uniprot |
T23 | Phosphorylation | P68400 (CSNK2A1) , P67870 (CSNK2B) | Uniprot |
K58 | Sumoylation | Uniprot | |
T61 | Phosphorylation | Uniprot | |
S63 | Phosphorylation | P68400 (CSNK2A1) , P67870 (CSNK2B) | Uniprot |
R83 | Methylation | Uniprot | |
S88 | Phosphorylation | Uniprot | |
K91 | Ubiquitination | Uniprot | |
S95 | Phosphorylation | Uniprot | |
S101 | Phosphorylation | P68400 (CSNK2A1) , P67870 (CSNK2B) | Uniprot |
S105 | Phosphorylation | Uniprot | |
K116 | Acetylation | Uniprot | |
T140 | Phosphorylation | Uniprot | |
K157 | Ubiquitination | Uniprot | |
K165 | Ubiquitination | Uniprot | |
S168 | Phosphorylation | Uniprot | |
K171 | Acetylation | Uniprot | |
K171 | Sumoylation | Uniprot | |
K171 | Ubiquitination | Uniprot | |
K174 | Ubiquitination | Uniprot | |
S214 | Phosphorylation | Q06187 (BTK) | Uniprot |
S215 | Phosphorylation | Q06187 (BTK) | Uniprot |
K220 | Ubiquitination | Uniprot | |
K241 | Sumoylation | Uniprot | |
K241 | Ubiquitination | Uniprot | |
K255 | Ubiquitination | Uniprot | |
S258 | Phosphorylation | Uniprot | |
S261 | Phosphorylation | Uniprot | |
S269 | Phosphorylation | Uniprot | |
K273 | Ubiquitination | Uniprot | |
K281 | Ubiquitination | Uniprot | |
K286 | Ubiquitination | Uniprot | |
S289 | Phosphorylation | Uniprot | |
T291 | Phosphorylation | Uniprot | |
Y293 | Phosphorylation | Uniprot | |
S295 | Phosphorylation | P68400 (CSNK2A1) , P67870 (CSNK2B) | Uniprot |
S296 | Phosphorylation | Uniprot | |
S298 | Phosphorylation | Uniprot | |
Y299 | Phosphorylation | Uniprot | |
K301 | Ubiquitination | Uniprot | |
Y321 | Phosphorylation | Uniprot | |
T333 | Phosphorylation | Uniprot | |
S345 | Phosphorylation | Uniprot | |
Y348 | Phosphorylation | Uniprot | |
T358 | Phosphorylation | Uniprot | |
S361 | Phosphorylation | P43405 (SYK) | Uniprot |
S364 | Phosphorylation | P43405 (SYK) | Uniprot |
S368 | Phosphorylation | Uniprot | |
S377 | Phosphorylation | Uniprot | |
K378 | Ubiquitination | Uniprot | |
K380 | Ubiquitination | Uniprot | |
S389 | Phosphorylation | Uniprot | |
S391 | Phosphorylation | Uniprot | |
S393 | Phosphorylation | Uniprot | |
S397 | Phosphorylation | Uniprot | |
T398 | Phosphorylation | Uniprot | |
S402 | Phosphorylation | Uniprot | |
S409 | Phosphorylation | Uniprot | |
Y413 | Phosphorylation | Uniprot | |
T415 | Phosphorylation | Uniprot | |
S427 | Phosphorylation | Uniprot | |
K429 | Sumoylation | Uniprot | |
K429 | Ubiquitination | Uniprot | |
Y435 | Phosphorylation | Uniprot | |
S442 | Phosphorylation | Uniprot | |
S445 | Phosphorylation | Uniprot | |
K460 | Ubiquitination | Uniprot |
Research Backgrounds
Transcription regulator of hematopoietic cell differentiation. Binds gamma-satellite DNA. Plays a role in the development of lymphocytes, B- and T-cells. Binds and activates the enhancer (delta-A element) of the CD3-delta gene. Repressor of the TDT (fikzfterminal deoxynucleotidyltransferase) gene during thymocyte differentiation. Regulates transcription through association with both HDAC-dependent and HDAC-independent complexes. Targets the 2 chromatin-remodeling complexes, NuRD and BAF (SWI/SNF), in a single complex (PYR complex), to the beta-globin locus in adult erythrocytes. Increases normal apoptosis in adult erythroid cells. Confers early temporal competence to retinal progenitor cells (RPCs) (By similarity). Function is isoform-specific and is modulated by dominant-negative inactive isoforms.
Phosphorylation controls cell-cycle progression from late G(1) stage to S stage. Hyperphosphorylated during G2/M phase. Dephosphorylated state during late G(1) phase. Phosphorylation on Thr-140 is required for DNA and pericentromeric location during mitosis. CK2 is the main kinase, in vitro. GSK3 and CDK may also contribute to phosphorylation of the C-terminal serine and threonine residues. Phosphorylation on these C-terminal residues reduces the DNA-binding ability. Phosphorylation/dephosphorylation events on Ser-13 and Ser-295 regulate TDT expression during thymocyte differentiation. Dephosphorylation by protein phosphatase 1 regulates stability and pericentromeric heterochromatin location. Phosphorylated in both lymphoid and non-lymphoid tissues (By similarity). Phosphorylation at Ser-361 and Ser-364 downstream of SYK induces nuclear translocation.
Sumoylated. Simulataneous sumoylation on the 2 sites results in a loss of both HDAC-dependent and HDAC-independent repression. Has no effect on pericentromeric heterochromatin location. Desumoylated by SENP1 (By similarity).
Polyubiquitinated.
Nucleus.
Note: In resting lymphocytes, distributed diffusely throughout the nucleus. Localizes to pericentromeric heterochromatin in proliferating cells. This localization requires DNA binding which is regulated by phosphorylation / dephosphorylation events.
Nucleus.
Note: In resting lymphocytes, distributed diffusely throughout the nucleus. Localizes to pericentromeric heterochromatin in proliferating cells. This localization requires DNA binding which is regulated by phosphorylation / dephosphorylation events (By similarity).
Cytoplasm.
Abundantly expressed in thymus, spleen and peripheral blood Leukocytes and lymph nodes. Lower expression in bone marrow and small intestine.
Heterodimer formed by the various isoforms; this modulates transcription regulator activity. Heterodimer with other IKAROS family members. Interacts with IKZF4 AND IKZF5. Component of the chromatin-remodeling NuRD repressor complex which includes at least HDAC1, HDAC2, RBBP4, RBBP7, IKZF1, MTA2, MBD2, MBD3, MTA1L1, CHD3 and CHD4. Interacts directly with the CHD4 component of the NuRD complex. Interacts directly with SMARCA4; the interaction associates IKFZ1 with the BAF complex. Interacts with SUMO1; the interaction sumoylates IKAROS, promoted by PIAS2 and PIAS3. Interacts with PIAS2 (isoform alpha); the interaction promotes sumoylation and reduces transcription repression. Interacts, to a lesser extent, with PIAS3. Interacts with PPP1CC; the interaction targets PPP1CC to pericentromeric heterochromatin, dephosphorylates IKAROS, stabilizes it and prevents it from degradation. Interacts with IKZF3 (By similarity).
The N-terminal zinc-fingers 2 and 3 are required for DNA binding as well as for targeting IKFZ1 to pericentromeric heterochromatin.
The C-terminal zinc-finger domain is required for dimerization.
Belongs to the Ikaros C2H2-type zinc-finger protein family.
References
Application: WB Species: Human Sample: ARP-1 and RPMI-8226 cells
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.